Under the partnership, the new platform will utilize Open AI as well as Syneos Health’s technology and data analyzations to optimize clinical trial efficiencies, according to a March 20 press release from Syneos Health.
The aim is to improve trial site selection and reduce enrollment timelines.
Conditions of the partnership were not disclosed.